CAM
ZYME icon

Cresset Asset Management’s Zymeworks ZYME Stock Holding History

Cresset Asset Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,120
Closed -$214K – 1808
2025
Q4 		$214K Buy
+8,120
New +$177K ﹤0.01% 1459
2025
Q3 		– Sell
-12,153
Closed -$153K – 1592
2025
Q2 		$153K Sell
12,153
-9,167
-43% -$109K ﹤0.01% 1329
2025
Q1 		$254K Sell
21,320
-9,486
-31% -$129K ﹤0.01% 1405
2024
Q4 		$451K Sell
30,806
-8,583
-22% -$120K ﹤0.01% 1136
2024
Q3 		$494K Sell
39,389
-11,211
-22% -$122K ﹤0.01% 1525
2024
Q2 		$431K Buy
+50,600
New +$450K ﹤0.01% 1515

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cresset Asset Management's ZYME Position: Q1 2026 in Review

Cresset Asset Management sold out of Zymeworks (ZYME) in Q1 2026, closing a stake of 8,120 shares — an estimated $214K sold.

Cresset Asset Management first reported a position in ZYME in Q2 2024 and held it in 6 quarters. The position peaked at $494K in Q3 2024. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Cresset Asset Management reported no remaining Zymeworks position as of Q1 2026 after selling out during the quarter.
  • Cresset Asset Management sold 8,120 Zymeworks shares in Q1 2026, an estimated $214K.
  • Cresset Asset Management first reported a position in Zymeworks in Q2 2024 and held it in 6 quarters.
  • Cresset Asset Management's Zymeworks position peaked at $494K in Q3 2024.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.